DaVita Inc.
Moat Score — DaVita Inc.
Total Moat Score
15 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 2 / 5 | DaVita's advantage comes from clinical licensure, accumulated operating protocols, and quality-outcomes data rather than a consumer brand or patents; state certificate-of-need rules in some markets add a modest regulatory barrier. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 3 / 5 | Scale purchasing of dialysis supplies and drugs, plus local center density, give DaVita real cost advantages over small independent operators, though it competes on largely equal footing with similarly scaled Fresenius. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 2 / 5 | The majority of DaVita's patients are covered by fixed Medicare bundled rates, leaving pricing power concentrated in a minority of commercially-insured patients who effectively subsidize the rest — a structurally limited form of pricing leverage. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 0 / 5 | Dialysis is a clinical service delivered locally; one patient's use of a DaVita center does not make the service more valuable to another patient, so there is no network effect. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 4 / 5 | Patients require dialysis three times a week for life, need a clinic near home, and build ongoing relationships with clinical staff and physicians, making switching centers disruptive and rare once a patient is established. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 4 / 5 | DaVita and Fresenius together operate the large majority of U.S. dialysis clinics; building a competing local clinic network from scratch is capital-intensive and slow, and the resulting concentration has repeatedly drawn antitrust scrutiny — evidence of genuine efficient-scale dynamics. |